Fragment Discovery for the Design of Nitrogen Heterocycles asMycobacterium tuberculosisDihydrofolate Reductase Inhibitors
Author:
Affiliation:
1. Institute of Chemical Technology; Nathalal Parekh Marg, Matunga; Mumbai India
2. Radiation Medicine Centre; Tata Memorial Hospital, Parel; Mumbai India
Funder
UGC (SAP)
Publisher
Wiley
Subject
Drug Discovery,Pharmaceutical Science
Reference61 articles.
1. 2015
2. XDR Tuberculosis — Implications for Global Public Health
3. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases
4. DNA and RNA Synthesis: Antifolates
5. Structure-activity relationships of dihydrofolated reductase inhibitors
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances in Fragment-based strategies against tuberculosis;European Journal of Medicinal Chemistry;2023-10
2. Synthesis and activity study of novel theophylline derivatives as IDO1 inhibitors;2023-06-12
3. Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors: State of Art Past 20 Years;BIOINTERFACE RES APP;2023
4. Exploring the potential and identifying Withania somnifera alkaloids as novel dihydrofolate reductase (DHFR) inhibitors by the AlteQ method;Journal of Biomolecular Structure and Dynamics;2023-02-10
5. Recent Advances in the Biological Significance of Xanthine and its Derivatives: A Review;Pharmaceutical Chemistry Journal;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3